加拿大-话题@MedSci

#加拿大#

187篇内容 | 4022人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1312667, encodeId=c324131266e7f, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=Emgality（galcanezumab）治疗阵发性丛集性头痛：已在加拿大获得批准, objectType=article, longId=207661, objectId=8a1820e661cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a1820e661cb, replyNumber=0, likeNumber=87, createdTime=2021-02-28, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a1820e661cb, moduleTitle=Emgality（galcanezumab）治疗阵发性丛集性头痛：已在加拿大获得批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a1820e661cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312666, encodeId=fd371312666b1, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=英国、美国、欧盟和加拿大开始对COVID-19疫苗NVX-CoV2373进行滚动审查, objectType=article, longId=206930, objectId=6f5c20693047, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5c20693047, replyNumber=0, likeNumber=66, createdTime=2021-02-10, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5c20693047, moduleTitle=英国、美国、欧盟和加拿大开始对COVID-19疫苗NVX-CoV2373进行滚动审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f5c20693047)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312665, encodeId=923c131266554, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=BMJ：加拿大TIA评分用于短暂性脑缺血发作患者后续中风风险评估, objectType=article, longId=206917, objectId=c8a920691e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8a920691e5f, replyNumber=0, likeNumber=77, createdTime=2021-02-09, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8a920691e5f, moduleTitle=BMJ：加拿大TIA评分用于短暂性脑缺血发作患者后续中风风险评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8a920691e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312664, encodeId=bae013126648e, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=Allergy：加拿大、欧洲、南非和美国过敏性成年人对屋尘螨敏感情况的比较 , objectType=article, longId=206745, objectId=7f19206e4570, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f19206e4570, replyNumber=0, likeNumber=76, createdTime=2021-02-05, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f19206e4570, moduleTitle=Allergy：加拿大、欧洲、南非和美国过敏性成年人对屋尘螨敏感情况的比较 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f19206e4570)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312663, encodeId=1ff3131266329, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=加拿大蒙特利尔心脏研究所（MHI）：秋水仙碱降低了COVID-19相关并发症的风险, objectType=article, longId=206222, objectId=1bea206222ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bea206222ba, replyNumber=0, likeNumber=79, createdTime=2021-01-27, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bea206222ba, moduleTitle=加拿大蒙特利尔心脏研究所（MHI）：秋水仙碱降低了COVID-19相关并发症的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bea206222ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312662, encodeId=b68f131266209, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可, objectType=article, longId=205999, objectId=0f8e205999ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f8e205999ca, replyNumber=0, likeNumber=77, createdTime=2021-01-23, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f8e205999ca, moduleTitle=知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f8e205999ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312661, encodeId=a30113126619a, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=美国、加拿大暴发沙门氏菌感染，它是导致腹泻的重要元凶！, objectType=article, longId=204798, objectId=b2d8204e987c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2d8204e987c, replyNumber=0, likeNumber=53, createdTime=2020-12-24, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2d8204e987c, moduleTitle=美国、加拿大暴发沙门氏菌感染，它是导致腹泻的重要元凶！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2d8204e987c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312660, encodeId=a79f1312660a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=加拿大政府宣布，加速基于干细胞的1型糖尿病疗法, objectType=article, longId=203945, objectId=cc0420394509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc0420394509, replyNumber=0, likeNumber=106, createdTime=2020-12-02, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc0420394509, moduleTitle=加拿大政府宣布，加速基于干细胞的1型糖尿病疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc0420394509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312659, encodeId=f34413126591c, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, objectType=article, longId=201927, objectId=300020192e1c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=300020192e1c, replyNumber=0, likeNumber=80, createdTime=2020-10-12, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=300020192e1c, moduleTitle=辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=300020192e1c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312658, encodeId=feda131265801, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=NERLYNX（neratinib）治疗HER2阳性转移性乳腺癌：将在加拿大获得批准, objectType=article, longId=200277, objectId=dacc2002e766, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dacc2002e766, replyNumber=0, likeNumber=75, createdTime=2020-09-06, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dacc2002e766, moduleTitle=NERLYNX（neratinib）治疗HER2阳性转移性乳腺癌：将在加拿大获得批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dacc2002e766)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312657, encodeId=0562131265e96, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂, objectType=article, longId=199606, objectId=6ec41996063c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ec41996063c, replyNumber=0, likeNumber=83, createdTime=2020-08-19, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ec41996063c, moduleTitle=Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ec41996063c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312656, encodeId=3e2a131265665, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！, objectType=article, longId=199604, objectId=69a719960403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a719960403, replyNumber=0, likeNumber=92, createdTime=2020-08-19, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a719960403, moduleTitle=Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a719960403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312655, encodeId=753f1312655c2, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=CMAJ：肥胖是一种慢性病！加拿大肥胖管理指南, objectType=article, longId=199506, objectId=c0e519950668, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0e519950668, replyNumber=0, likeNumber=90, createdTime=2020-08-17, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0e519950668, moduleTitle=CMAJ：肥胖是一种慢性病！加拿大肥胖管理指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0e519950668)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312654, encodeId=4ae41312654e3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=Mol. Pharmaceutics：加拿大科学家开发新方法，可将抗癌药物**输送到肿瘤, objectType=article, longId=197115, objectId=0a7519e1151f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a7519e1151f, replyNumber=0, likeNumber=71, createdTime=2020-07-07, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a7519e1151f, moduleTitle=Mol. Pharmaceutics：加拿大科学家开发新方法，可将抗癌药物**输送到肿瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a7519e1151f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312653, encodeId=defd1312653ad, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=JACC:经食管超声指导心脏介入治疗，近九成患者出现食管或胃损伤！加拿大前瞻性研究, objectType=article, longId=196622, objectId=41f119662202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41f119662202, replyNumber=0, likeNumber=66, createdTime=2020-06-29, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41f119662202, moduleTitle=JACC:经食管超声指导心脏介入治疗，近九成患者出现食管或胃损伤！加拿大前瞻性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41f119662202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312652, encodeId=aa811312652d4, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, objectType=article, longId=194148, objectId=4528194148c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4528194148c3, replyNumber=0, likeNumber=75, createdTime=2020-05-16, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4528194148c3, moduleTitle=加拿大卫生部批准首例新冠病毒抗体的血清学测试, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4528194148c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312651, encodeId=ecac1312651a3, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, objectType=article, longId=193904, objectId=7e121939040f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e121939040f, replyNumber=0, likeNumber=90, createdTime=2020-05-12, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e121939040f, moduleTitle=新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e121939040f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312650, encodeId=e86e1312650d9, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, objectType=article, longId=193606, objectId=c7931936061f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7931936061f, replyNumber=0, likeNumber=81, createdTime=2020-05-08, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7931936061f, moduleTitle=加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7931936061f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312649, encodeId=2576131264912, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=加拿大新冠肺炎快速检测盒被发现检测结果不可靠, objectType=article, longId=193518, objectId=b137193518af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b137193518af, replyNumber=0, likeNumber=0, createdTime=2020-05-06, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b137193518af, moduleTitle=加拿大新冠肺炎快速检测盒被发现检测结果不可靠, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b137193518af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1312648, encodeId=aec013126481a, content=<a href='/topic/show?id=1aa333006b4' target=_blank style='color:#2F92EE;'>#加拿大#</a>, objectTitle=左室射血分数<35%的冠心病或应**搭桥手术！JAMA子刊加拿大回顾性研究, objectType=article, longId=192039, objectId=f0bb1920393e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0bb1920393e, replyNumber=0, likeNumber=76, createdTime=2020-04-13, rootId=0, userName=shanyongle, userId=279b407, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0bb1920393e, moduleTitle=左室射血分数<35%的冠心病或应**搭桥手术！JAMA子刊加拿大回顾性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0bb1920393e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

加拿大

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

Emgality（galcanezumab）治疗阵发性丛集性头痛：已在加拿大获得批准

2021-02-28

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

英国、美国、欧盟和加拿大开始对COVID-19疫苗NVX-CoV2373进行滚动审查

2021-02-10

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

BMJ：加拿大TIA评分用于短暂性脑缺血发作患者后续中风风险评估

2021-02-09

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

Allergy：加拿大、欧洲、南非和美国过敏性成年人对屋尘螨敏感情况的比较

2021-02-05

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

加拿大蒙特利尔心脏研究所（MHI）：秋水仙碱降低了COVID-19相关并发症的风险

2021-01-27

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

知临集团从加拿大公共卫生局获得启动ALS-4——用于治疗金黄色葡萄球菌（包括耐甲氧西林金黄色葡萄球菌（MRSA））感染的小分子药物——的临床1期试验许可

2021-01-23

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

美国、加拿大暴发沙门氏菌感染，它是导致腹泻的重要元凶！

2020-12-24

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

加拿大政府宣布，加速基于干细胞的1型糖尿病疗法

2020-12-02

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

辉瑞加拿大公司和BioNTech开始向加拿大卫生部提交SARS-CoV-2疫苗候选BNT162b2的滚动申请

2020-10-12

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

NERLYNX（neratinib）治疗HER2阳性转移性乳腺癌：将在加拿大获得批准

2020-09-06

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

Can J Cardiol：加拿大声明称电风暴优选非选择性β阻滞剂

2020-08-19

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

Can J Cardiol：加拿大声明，心脏淀粉样变合并心衰有5特征！

2020-08-19

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

CMAJ：肥胖是一种慢性病！加拿大肥胖管理指南

2020-08-17

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

Mol. Pharmaceutics：加拿大科学家开发新方法，可将抗癌药物**输送到肿瘤

2020-07-07

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

JACC:经食管超声指导心脏介入治疗，近九成患者出现食管或胃损伤！加拿大前瞻性研究

2020-06-29

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

加拿大卫生部批准首例新冠病毒抗体的血清学测试

2020-05-16

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

新型DPEP-1多肽抑制剂Metablok抗击COVID-19：加拿大卫生部批准II期临床

2020-05-12

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

加拿大批准BCL-2抑制剂VENCLEXTA与CD20单抗Obinutuzumab联合，用于先前未治疗的慢性淋巴细胞性白血病患者

2020-05-08

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

加拿大新冠肺炎快速检测盒被发现检测结果不可靠

2020-05-06

shanyongle (审核中...)

前往app查看评论内容

#加拿大#

左室射血分数<35%的冠心病或应**搭桥手术！JAMA子刊加拿大回顾性研究

2020-04-13

科室
- - 订阅+
  - 更多科室
工具
服务